Skip to main content
Pharma Mar S.A. logo

Pharma Mar S.A. — Investor Relations & Filings

Ticker · PHM ISIN · ES0169501022 LEI · 959800QWKZ45ZQC2AV58 MC Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2025-10-28 Director's Dealing
Country ES Spain
Listing MC PHM

About Pharma Mar S.A.

https://pharmamar.com/en/

Pharma Mar S.A. is a biopharmaceutical company specializing in the discovery, development, and commercialization of oncology treatments derived from marine sources. A pioneer in its field since 1986, the company leverages marine biodiversity to develop innovative therapies for cancer, with a particular focus on rare tumors. Its integrated R&D pipeline spans from the exploration of marine invertebrates to the marketing of approved drugs. The company maintains an extensive collection of over 500,000 marine samples, which serves as the foundation for its drug discovery programs. Key commercialized products include Yondelis® (trabectedin) for advanced soft tissue sarcoma and ovarian cancer, Zepzelca® (lurbinectedin) for small cell lung cancer, and Aplidin® (plitidepsin) for multiple myeloma.

Recent filings

Filing Released Lang Actions
Motivo de la notificación: Persona con Responsabilidad de Dirección
Director's Dealing Classification · 100% confidence The document is a standard form for the notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMR). It explicitly identifies the individual (Rosa María Sánchez-Yebra Alonso), their role (Consejera), the issuer (Pharma Mar, S.A.), and details of a specific share purchase transaction (date, volume, price, and venue). This aligns perfectly with the definition of a Director's Dealing (DIRS) filing.
2025-10-28 Spanish
Motivo de la notificación: Persona con Responsabilidad de Dirección
Director's Dealing Classification · 100% confidence The document is a standard form for the notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMR). It explicitly identifies the individual (Fernando Martín-Delgado Santos), their role (Consejero), the issuer (Pharma Mar, S.A.), and details of the specific share purchase transaction (date, volume, price). This aligns perfectly with the definition of a Director's Dealing (DIRS) filing.
2025-10-24 Spanish
Motivo de la notificación: Persona con Responsabilidad de Dirección
Director's Dealing Classification · 100% confidence The document is a standard form for the notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMR). It explicitly identifies the individual (Soledad Cuenca Miranda), their role (Consejera/Director), the issuer (Pharma Mar, S.A.), and details of the financial transaction (purchase of shares). This aligns perfectly with the definition of a Director's Dealing (DIRS) filing.
2025-10-08 Spanish
Motivo de la notificación: Persona con Responsabilidad de Dirección
Director's Dealing Classification · 100% confidence The document is a standard form for the notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMR). It explicitly lists the name of the director (Soledad Cuenca Miranda), the issuer (Pharma Mar, S.A.), and details of share transactions (purchase and sale of shares). This aligns perfectly with the definition of 'Director's Dealing' (DIRS).
2025-09-22 Spanish
Motivo de la notificación: Persona con Responsabilidad de Dirección
Director's Dealing Classification · 100% confidence The document is explicitly titled 'STANDARD FORM FOR NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM'. This form details transactions (purchases of shares) made by a director ('CONSEJERA') of the issuer (PHARMA MAR, S.A.). This directly corresponds to the definition of Director's Dealing (insider trades). Reviewing the definitions: - 10-K/IR: Not a full annual or interim financial report. - ER/MDA: Not an earnings release or management discussion. - DEF 14A: Relates to remuneration, not insider transactions. - The most precise match is Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives.
2025-06-19 Spanish
Se informa que todas las propuestas de acuerdos presentadas por el Consejo a la Junta General han sido aprobadas.
AGM Information Classification · 100% confidence The document is a formal communication addressed to the Comisión Nacional del Mercado de Valores (CNMV) in Spain, dated June 18, 2025. It explicitly states that the Ordinary General Shareholders' Meeting (Junta General Ordinaria de accionistas) was held today and approved all proposals. The text details the resolutions passed, including the approval of the 2024 Annual Accounts, approval of the non-financial information report, approval of the application of results (including dividend distribution), approval of management performance, re-election of a director, authorization for share buybacks (POS activity), and approval of an employee share plan (POS activity). Since the document reports the *results* and *decisions* made during the Annual General Meeting, it directly relates to the proceedings of that meeting. The most appropriate classification is AGM-R (AGM Information), as it details the outcomes of the meeting itself, rather than being a preliminary proxy statement (PSI) or a general regulatory filing (RNS).
2025-06-18 Spanish

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.